GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK)
Operating Income Growth
34.13%
TTM · Period ending:
GSK Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported34.13%period ending
Latest reported34.13%period ending
GSK TTM Operating Income YoY % (250.31% → 34.13%)
Year-over-year change
High-resolution chart · PNG
GSK operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 301.0867% | |
| 546.8306% | |
| 204.0403% | |
| -97.3629% | |
| -19.3456% | |
| -49.6684% | |
| 16.5061% | |
| 25.4661% | |
| 13.9655% | |
| -47.6402% | |
| -52.5991% | |
| -67.7642% | |
| -72.2721% | |
| -43.3807% | |
| -42.0121% | |
| -49.515% | |
| 87.1821% | |
| 136.9333% | |
| 442.1409% | |
| 62.7365% | |
| -14.3084% | |
| -24.7651% | |
| -14.5318% | |
| 16.5573% | |
| 13.2343% | |
| 18.0062% | |
| 36.9842% | |
| 28.8435% | |
| 70.572% | |
| 61.5611% | |
| 9.1206% | |
| 75.2736% | |
| 107.6177% | |
| 346.5235% | |
| 985.299% | |
| 8,140.8651% | |
| 2,891.314% | |
| 1,280.7097% | |
| -627.0499% | |
| -102.2233% | |
| -106.8277% | |
| -83.7113% | |
| 170.9% | |
| 51.2583% | |
| 29.8394% | |
| -18.2103% | |
| -157.7725% | |
| 67.0202% | |
| 26.5432% | |
| -18.6112% | |
| -20.1745% | |
| -14.3092% | |
| 26.5544% | |
| 95.7117% | |
| 250.311% |